New Drugs and Devices for HF Therapy

Published: 31 July 2020

  • Views:

    Views Icon 297

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

This session was part of the 1st e-SPACE Heart Failure Meeting held virtually on July 11-14th 2020 and focuses on novel drugs and devices changing the treatment paradigm in Heart Failure management.

Agenda

  • Omecamtiv Mecarbil for Chronic HF - John Teerlink (University of San Francisco, San Francisco, US)
  • Devices for Functional MR beyond Mitraclip - Ralph Stephan von Bardeleben (University of Mainz, Mainz, DE)
  • Devices for Baroreflex Stimulation - Andrew Coats (Monash University, Melbourne, AU)
  • More on New Drugs and Devices on the Horizon - Stefan Anker (Charite University, Berlin, DE)

More from this programme

Part 1

Omecamtiv Mecarbil for Chronic HF

1 session
Omecamtiv Mecarbil for Chronic HF Watch now

Part 2

Devices for Functional MR beyond Mitraclip

1 session
Devices for Functional MR beyond Mitraclip Watch now

Part 3

Devices for Baroreflex Stimulation

1 session
Devices for Baroreflex Stimulation Watch now

Part 4

More on New Drugs and Devices on the Horizon

1 session
More on new drugs and devices on the horizon Watch now

Faculty Biographies

Stefan Anker

Stefan Anker

Professor of Cardiology

Prof Stefan Anker is professor of (Tissue) Homeostasis in Cardiology & Metabolism at Charité Berlin, Germany, since June 2017. Prodigious researcher who has authored more than 1,000 articles. He has also won several prizes, including the 2018 Copernicus Prize of German DFG & Polish FNP. In October 2020, he was awarded a Doctor honoris causa of Medical University Wroclaw, Poland.

Prof Anker has been serving on the board of the Heart Failure Association (HFA) of the ESC since 2006 and was HFA President from 2012 to 2014. He currently chairs the HFA committee on regulatory affairs. He is founding Editor-in-Chief of the first open-access heart failure journal, ESC Heart Failure. Prof. Anker has served on several ESC Guideline task forces.

Prof Anker is the founding president of the International Society on Sarcopenia, Cachexia and Wasting Disorders (SCWD) and founding Editor-in-Chief of the Journal of Cachexia, Sarcopenia and…

View full profile